BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1404666)

  • 1. The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1.
    Koo AS; Chiu R; Soong J; Dekernion JB; Belldegrun A
    J Urol; 1992 Oct; 148(4):1314-8. PubMed ID: 1404666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
    Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
    Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
    Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor.
    Li L; Hu JS; Olson EN
    J Biol Chem; 1990 Jan; 265(3):1556-62. PubMed ID: 2104845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation.
    Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC
    Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable induction of c-jun mRNA expression in normal human keratinocytes by agents that induce predifferentiation growth arrest.
    Blatti SP; Scott RE
    Cell Growth Differ; 1992 Jul; 3(7):429-34. PubMed ID: 1419906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells.
    Adachi K; Saito H
    J Clin Invest; 1992 May; 89(5):1657-61. PubMed ID: 1373742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
    Koo AS; Armstrong C; Bochner B; Shimabukuro T; Tso CL; deKernion JB; Belldegrum A
    Cancer Immunol Immunother; 1992; 35(2):97-105. PubMed ID: 1596939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production.
    Romieu R; Lacabanne V; Kayibanda M; Antoine B; Bennoun M; Chouaib S; Guillet JG; Viguier M
    Int Immunol; 1997 Oct; 9(10):1405-13. PubMed ID: 9352345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma.
    Baştürk B; Yavaşçaoğlu I; Vuruşkan H; Göral G; Oktay B; Oral HB
    Cytokine; 2005 Apr; 30(1):41-5. PubMed ID: 15784411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
    Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
    Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.
    Millena AC; Vo BT; Khan SA
    J Biol Chem; 2016 Aug; 291(34):17964-76. PubMed ID: 27358408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes.
    Maeurer MJ; Martin DM; Castelli C; Elder E; Leder G; Storkus WJ; Lotze MT
    Cancer Immunol Immunother; 1995 Aug; 41(2):111-21. PubMed ID: 7656270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1-mediated induction of junB is selectively inhibited by expression of Ad.12-E1A.
    Coussens LM; Yokoyama K; Chiu R
    J Cell Physiol; 1994 Sep; 160(3):435-44. PubMed ID: 8077281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells.
    McKay S; Hirst SJ; Haas MB; de Jongste JC; Hoogsteden HC; Saxena PR; Sharma HS
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):103-11. PubMed ID: 10873159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1, interleukin-8, tumour necrosis factor alpha and interferon gamma stimulate DNA synthesis but have no effect on apoptosis in small-intestinal cell lines.
    Zachrisson K; Neopikhanov V; Samali A; Uribe A
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):551-9. PubMed ID: 11396536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncogenic role of MUC12 in RCC progression depends on c-Jun/TGF-β signalling.
    Gao SL; Yin R; Zhang LF; Wang SM; Chen JS; Wu XY; Yue C; Zuo L; Tang M
    J Cell Mol Med; 2020 Aug; 24(15):8789-8802. PubMed ID: 32596961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.